SCA
ARKG icon

Sandy Cove Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Sandy Cove Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-256
Closed -$16K – 415
2021
Q4 		$16K Buy
+256
New +$17.7K 0.01% 277

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Sandy Cove Advisors's ARKG Position: Q1 2022 in Review

Sandy Cove Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 256 shares — an estimated $16K sold.

Sandy Cove Advisors first reported a position in ARKG in Q4 2021 and held it in 1 quarter. The position peaked at $16K in Q4 2021. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Sandy Cove Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Sandy Cove Advisors sold 256 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $16K.
  • Sandy Cove Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 1 quarter.
  • Sandy Cove Advisors's ARK Genomic Revolution ETF position peaked at $16K in Q4 2021.
  • 388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Sandy Cove Advisors's 13F filing for Q1 2022, filed 4 May 2022.